|
Market Closed -
Nasdaq
16:30:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 18.30 USD | -0.49% |
|
+0.44% | +92.83% |
| 08-13 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Company Valuation: Fortress Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 94.38 | - |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -16.92% | - |
| Enterprise Value (EV) | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 94.38 | 94.38 |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -16.92% | 0% |
| P/E | -3.16x | -0.68x | -0.36x | -0.75x | -52.3x | 1.11x | -2.83x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0x | 0x | 0.5x | -0x | 0x |
| Capitalization / Revenue | 3.62x | 0.94x | 0.65x | 0.97x | 1.8x | 1.2x | 0.83x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.2x | 0.83x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.87x | -5.86x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -11.85 | -14.55 | -8.47 | -2.69 | -0.07 | 2.55 | -1 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 68.79 | 75.74 | 84.51 | 57.68 | 63.26 | 78.79 | 113.2 |
| EBITDA | -188.5 | - | - | -107.3 | -65.56 | - | - |
| EBIT 1 | -188.5 | -203.6 | -142.3 | -110.4 | -70.22 | -32.9 | -16.11 |
| Net income 1 | -64.7 | -86.58 | -68.67 | -46 | -1.882 | 88.25 | -37.81 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 37.500 | 9.825 | 3.010 | 2.025 | 3.660 | 2.830 | 2.830 |
| Nbr of stocks (in thousands) | 6,642 | 7,241 | 18,131 | 27,605 | 31,038 | 33,351 | - |
| Announcement Date | 3/28/22 | 3/30/23 | 3/28/24 | 3/31/25 | 3/31/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.19x | 4.48x | 10.56x | 0.47% | 82.73B | |
| 19.91x | 4.26x | 13.15x | 2.49% | 57.94B | |
| -16.19x | 24.59x | -15.87x | -.--% | 55.45B | |
| 38.27x | 13.07x | 25.07x | -.--% | 52.57B | |
| 22.03x | 4.86x | 13.87x | 0.66% | 48.94B | |
| 38.76x | 3.56x | 13.56x | -.--% | 32.23B | |
| 57.11x | 3.65x | 28.31x | -.--% | 25.94B | |
| 73.65x | 7.15x | 47.83x | -.--% | 22.1B | |
| 23.69x | 5.09x | 13.26x | -.--% | 16.55B | |
| Average | 30.71x | 7.86x | 16.64x | 0.4% | 43.83B | |
| Weighted average by Cap. | 24.55x | 8.51x | 13.19x | 0.55% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
- Valuation Fortress Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
